The United States Trypanosoma cruzi Infection Study: Evidence for vector-borne transmission of the parasite that causes Chagas disease among United States blood donors

Transfusion

Volumn 52, Issue 9, 2012, Pages 1922-1930

  Cantey, Paul T ^a,b,c,d,e,f   Stramer, Susan L ^a,b,c,d,e,f   Townsend, Rebecca L ^a,b,c,d,e,f   Kamel, Hany ^a,b,c,d,e,f   Ofafa, Karen ^a,b,c,d,e,f   Todd, Charles W ^a,b,c,d,e,f   Currier, Mary ^a,b,c,d,e,f   Hand, Sheryl ^a,b,c,d,e,f   Varnado, Wendy ^a,b,c,d,e,f   Dotson, Ellen ^a,b,c,d,e,f   Hall, Chris ^a,b,c,d,e,f   Jett, Pamela L ^a,b,c,d,e,f   Montgomery, Susan P ^a,b,c,d,e,f  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b Scientific Support Office   (United States)

^c Blood Systems Incorporated   (United States)

^d MISSISSIPPI STATE DEPARTMENT OF HEALTH   (United States)

^e BERRY COLLEGE   (United States)

^f Mississippi Blood Services   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLOOD CULTURE; BLOOD DONOR; CHAGAS DISEASE; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PARASITE TRANSMISSION; QUESTIONNAIRE; RADIOIMMUNOPRECIPITATION; RESERVOIR; RISK FACTOR; RURAL AREA; SEROLOGY; UNITED STATES; VECTOR BORNE INFECTION;

ADOLESCENT; ADULT; AGED; ANIMALS; BLOOD DONORS; BLOOD TRANSFUSION; CHAGAS DISEASE; COHORT STUDIES; DISEASE VECTORS; FEMALE; HUMANS; MALE; MIDDLE AGED; MISSISSIPPI; QUESTIONNAIRES; TRYPANOSOMA CRUZI; UNITED STATES; YOUNG ADULT;

EID: 84865733448     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2012.03581.x     Document Type: Article

References (28)

1. Bern C, Montgomery SP, Herwaldt BL, Rassi A Jr., Marin-Neto JA, Dantas RO, Maguire JH, Acquatella H, Morillo C, Kirchhoff LV, Gilman RH, Reyes PA, Salvatella R, Moore AC,. Evaluation and treatment of Chagas disease in the United States: a systematic review. JAMA 2007; 298: 2171-81.
2. Rassi JA, Rassi A, Marin-Neto JA,. Chagas disease. Lancet 2010; 375: 1388-402.
3. Woody NC, Woody HB,. American trypanosomiasis (Chagas' disease): first indigenous case in the United States. J Am Med Assoc 1955; 159: 676-7.
4. Anonymous. Found: two cases of Chagas disease. Texas Health Bull 1956; 9: 11-3.
5. Schiffler RJ, Mansur GP, Navin TR, Limpakarnjanarat K,. Indigenous Chagas' disease (American trypanosomiasis) in California. JAMA 1984; 251: 2983-4.
6. Ochs DE, Hnilica VS, Moser DR, Smith JH, Kirchhoff LV,. Postmortem diagnosis of autochthonous acute chagasic myocarditis by polymerase chain reaction amplification of a species-specific DNA sequence of Trypanosoma cruzi. Am J Trop Med Hyg 1996; 54: 526-9.
7. Herwaldt BL, Grijalva MJ, Newsome AL, McGhee CR, Powell MR, Nemec DG, Steurer FJ, Eberhard ML,. Use of polymerase chain reaction to diagnose the fifth reported US case of autochthonous transmission of Trypanosoma cruzi, in Tennessee, 1998. J Infect Dis 2000; 181: 395-9.
8. Dorn PL, Perniciaro L, Yabsley MJ, Roellig DM, Balsamo G, Diaz J, Wesson D,. Autochthonous transmission of Trypanosoma cruzi, Louisiana. Emerg Infect Dis 2007; 13: 605-7.
9. Kjos SA, Snowden KF, Olson JK,. Biogeography and Trypanosoma cruzi infection prevalence of Chagas disease vectors in Texas, USA. Vector Borne Zoonotic Dis 2009; 9: 41-50.
10. WHO. WHO consultation on international biological reference preparations for Chagas disease. Geneva: WHO; 2007.
11. Bern C,. Antitrypanosomal therapy for chronic Chagas' disease. NEJM 2011; 364: 2527-34.
12. Jazin EE, Luquetti AO, Rassi A, Frasch AC,. Shift of excretory-secretory immunogens of Trypanosoma cruzi during human Chagas' disease. Infect Immun 1991; 59: 2189-91.
13. Umezawa ES, Nascimento MS, Kesper N Jr., Coura JR, Borges-Pereira J, Junqueira AC, Camargo ME,. Immunoblot assay using excreted-secreted antigens of Trypanosoma cruzi in serodiagnosis of congenital, acute, and chronic Chagas' disease. J Clin Microbiol 1996; 34: 2143-7.
14. Silveira-Lacerda EP, Silva AG, Junior SF, Souza MA, Kesper N, Botelho-Filho A, Umezawa ES,. Chagas' disease: application of TESA-blot in inconclusive sera from a Brazilian blood bank. Vox Sang 2004; 87: 204-7.
15. Leiby DA, Wendel S, Takaoka DT, Fachini RM, Oliveira LC, Tibbals MA,. Serologic testing for Trypanosoma cruzi: comparison of radioimmunoprecipitation assay with commercially available indirect immunofluorescence assay, indirect hemagglutination assay, and enzyme-linked immunosorbent assay kits. J Clin Microbiol 2000; 38: 639-42.
16. Winkler MA, Brashear RJ, Hall HJ, Schur JD, Pan AA,. Detection of antibodies to Trypanosoma cruzi among blood donors in the southwestern and western United States. II. Evaluation of a supplemental enzyme immunoassay and radioimmunoprecipitation assay for confirmation of seroreactivity. Transfusion 1995; 35: 219-25.
17. Kirchhoff LV, Gam AA, Gusmao RA, Goldsmith RS, Rezende JM, Rassi A,. Increased specificity of serodiagnosis of Chagas' disease by detection of antibody to the 72- and 90-kilodalton glycoproteins of Trypanosoma cruzi. J Infect Dis 1987; 155: 561-4.
18. Bern C, Montgomery SP, Katz L, Caglioti S, Stramer SL,. Chagas disease and the US blood supply. Curr Opin Infect Dis 2008; 21: 476-82.
19. Stramer SL, Townsend RL, Foster A, Krystif E, Leiby DA, Brodsky P, Rouault C, Lenes A, Dodd Y,. Experience with selective testing for antibody to Trypanosoma cruzi following validation using universal testing [abstract]. Vox Sang 2010; 99: 313-14.
20. Leiby DA, Herron RM Jr., Garratty G, Herwaldt BL,. Trypanosoma cruzi parasitemia in US blood donors with serologic evidence of infection. J Infect Dis 2008; 198: 609-13.
21. Bern C, Kjos S, Yabsley MJ, Montgomery SP,. Trypanosoma cruzi and Chagas' disease in the United States. Clin Microbiol Rev 2011; 24: 655-81.
22. Otani MM, Vinelli E, Kirchhoff LV, del Pozo A, Sands A, Vercauteren G, Sabino EC,. WHO comparative evaluation of serologic assays for Chagas disease. Transfusion 2009; 49: 1076-82.
23. Umezawa ES, Luquetti AO, Levitus G, Ponce C, Ponce E, Henriquez D, Revollo S, Espinoza B, Sousa O, Khan B, da Silveira JF,. Serodiagnosis of chronic and acute Chagas' disease with Trypanosoma cruzi recombinant proteins: results of a collaborative study in six Latin American countries. J Clin Microbiol 2004; 42: 449-52.
24. Ortho-Clinical Diagnostics, Inc. Ortho T. cruzi ELISA test system. Raritan, NJ: Ortho-Clinical Diagnostics, Inc.; 2006.
25. Wiener Laboratories. Chagatest ELISA recombinant v.3.0. Rosario, Argentina: Wiener Laboratories; 2000.
26. Cassandra D, Steurer F, Czaicki N, Todd C,. Determination of the sensitivity and specificity of three serodiagnostic assays for Chagas disease by latent class analysis [abstract]. Am J Trop Med Hyg 2011; 85: 256.
27. Blood donor screening for chagas disease-United States, 2006-2007. MMWR Morb Mortal Wkly Rep 2007; 56: 141-3.
28. Saez-Alquezar A, Otani MM, Sabino EC, Ribeiro-dos-Santos G, Salles N, Chamone DF,. Evaluation of the performance of Brazilian blood banks in testing for Chagas' disease. Vox Sang 1998; 74: 228-31.